Argent Trust CO Charles River Laboratories International, Inc. Transaction History

Argent Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $2,041 - $3,024	-10 Reduced 0.69%	1,441 $308,000
Q1 2022 May 11, 2022	BUY	$255.51 - $362.11 $47,269 - $66,990	185 Added 14.61%	1,451 $412,000
Q4 2021 Feb 09, 2022	BUY	$351.38 - $448.68 $10,541 - $13,460	30 Added 2.43%	1,266 $477,000
Q3 2021 Nov 09, 2021	BUY	$372.64 - $458.3 $42,108 - $51,787	113 Added 10.06%	1,236 $510,000
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $10,001 - $12,636	34 Added 3.12%	1,123 $416,000
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $271,890 - $326,133	1,089 New	1,089 $315,000

710

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.